234 related articles for article (PubMed ID: 25139038)
21. Levels of antiangiogenic factors in preeclamptic pregnancies.
Zhao W; Qiao J; Zhang Q; Zhao Y; Chen Q
Growth Factors; 2010 Aug; 28(4):293-8. PubMed ID: 20214506
[TBL] [Abstract][Full Text] [Related]
22. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications.
Ahmed A
Thromb Res; 2011 Feb; 127 Suppl 3():S72-5. PubMed ID: 21262447
[TBL] [Abstract][Full Text] [Related]
23. [The role of angiogenic factors in preeclampsia].
Alasztics B; Gullai N; Molvarec A; Rigó J
Orv Hetil; 2014 Nov; 155(47):1860-6. PubMed ID: 25403279
[TBL] [Abstract][Full Text] [Related]
24. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells.
Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ
J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845
[TBL] [Abstract][Full Text] [Related]
25. Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders.
Khalil A; Muttukrishna S; Harrington K; Jauniaux E
PLoS One; 2008 Jul; 3(7):e2766. PubMed ID: 18648513
[TBL] [Abstract][Full Text] [Related]
26. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
Luo X; Liu DD; Qi HB; Yao ZW
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
[TBL] [Abstract][Full Text] [Related]
27. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
[TBL] [Abstract][Full Text] [Related]
29. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ
Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901
[TBL] [Abstract][Full Text] [Related]
30. Soluble endoglin contributes to the pathogenesis of preeclampsia.
Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
[TBL] [Abstract][Full Text] [Related]
31. Hyperglycemia impairs cytotrophoblast function via stress signaling.
Cawyer CR; Horvat D; Leonard D; Allen SR; Jones RO; Zawieja DC; Kuehl TJ; Uddin MN
Am J Obstet Gynecol; 2014 Nov; 211(5):541.e1-8. PubMed ID: 24793974
[TBL] [Abstract][Full Text] [Related]
32. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
Brownfoot FC; Hannan NJ; Cannon P; Nguyen V; Hastie R; Parry LJ; Senadheera S; Tuohey L; Tong S; Kaitu'u-Lino TJ
EBioMedicine; 2019 Mar; 41():636-648. PubMed ID: 30824385
[TBL] [Abstract][Full Text] [Related]
33. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
[TBL] [Abstract][Full Text] [Related]
34. The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia.
Abascal-Saiz A; Duque-Alcorta M; Fioravantti V; Antolín E; Fuente-Luelmo E; Haro M; Ramos-Álvarez MP; Perdomo G; Bartha JL
Nutrients; 2022 May; 14(10):. PubMed ID: 35631313
[TBL] [Abstract][Full Text] [Related]
35. Effect of sildenafil citrate on circulating levels of sFlt-1 in preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Cannon P; Nguyen V; Kaitu'u-Lino TJ
Pregnancy Hypertens; 2018 Jul; 13():1-6. PubMed ID: 30177033
[TBL] [Abstract][Full Text] [Related]
36. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
[TBL] [Abstract][Full Text] [Related]
37. Placental origins of angiogenic dysfunction in mirror syndrome.
Bixel K; Silasi M; Zelop CM; Lim KH; Zsengeller Z; Stillman IE; Rana S
Hypertens Pregnancy; 2012; 31(2):211-7. PubMed ID: 22150085
[TBL] [Abstract][Full Text] [Related]
38. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
39. The SK3 channel promotes placental vascularization by enhancing secretion of angiogenic factors.
Rada CC; Murray G; England SK
Am J Physiol Endocrinol Metab; 2014 Nov; 307(10):E935-43. PubMed ID: 25249506
[TBL] [Abstract][Full Text] [Related]
40. A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling.
Saito S; Nakashima A
J Reprod Immunol; 2014 Mar; 101-102():80-88. PubMed ID: 23969229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]